Deliver to SINGAPORE
For best experience Get the App
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
TrustPilot
Rajesh P.
2天前
Pooja R.
1 周前
Neha S.
2 周前
Anjali K.
1 个月前
